Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Pharmaceuticals Reports 2008 Audited Results and Provides Corporate Update Mar 24, 2009 Tekmira Pharmaceuticals Reports 2008 Audited Results and Provides Corporate Update 32.6 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory Mar 18, 2009 Tekmira Pharmaceuticals Conference Call Advisory 12.7 KB 2008 Audited Results and Corporate Update ... Read more Summary ToggleTekmira Presents Data Demonstrating Further Increases in SNALP Potency Feb 24, 2009 Tekmira Presents Data Demonstrating Further Increases in SNALP Potency 17.8 KB ... Read more Summary ToggleTekmira Publishes PLK1 SNALP Anti-Tumor Efficacy Data Feb 23, 2009 Tekmira Publishes PLK1 SNALP Anti-Tumor Efficacy Data 17.8 KB ... Read more Summary ToggleTekmira Partner Alnylam Presents Data on Programs Using Tekmira’s SNALP Technology at Keystone Meeting Feb 12, 2009 ... Read more Summary ToggleTekmira Partner Alnylam Receives Clearance from FDA to Initiate Clinical Trial Utilizing SNALP Jan 23, 2009 Tekmira Partner Alnylam Receives Clearance from FDA to Initiate Clinical Trial Utilizing SNALP 15.9 KB ... Read more Summary ToggleTekmira Announces $11.2 million 3-Year Manufacturing and Development Commitment from Partner Alnylam Jan 08, 2009 Tekmira Announces $11.2 million 3-Year Manufacturing and Development Commitment from Partner Alnylam 17.3 KB ... Read more Summary ToggleTekmira Partner Alnylam Files First IND for an RNAi Therapeutic Utilizing SNALP Dec 23, 2008 Tekmira Partner Alnylam Files First IND for an RNAi Therapeutic Utilizing SNALP 16.7 KB ... Read more Summary ToggleTekmira Pharmaceuticals Corporation Announces Third Quarter 2008 Operating Results and Provides Program Update Nov 13, 2008 Tekmira Pharmaceuticals Corporation Announces Third Quarter 2008 Operating Results and Provides Program Update 28.1 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory Nov 10, 2008 Tekmira Pharmaceuticals Conference Call Advisory 12.2 KB 2008 Third Quarter Operating Results ... Read more Pagination First page First Previous page Previous … Page 47 Current page 48 Page 49 Page 50 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Pharmaceuticals Reports 2008 Audited Results and Provides Corporate Update Mar 24, 2009 Tekmira Pharmaceuticals Reports 2008 Audited Results and Provides Corporate Update 32.6 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory Mar 18, 2009 Tekmira Pharmaceuticals Conference Call Advisory 12.7 KB 2008 Audited Results and Corporate Update ... Read more Summary ToggleTekmira Presents Data Demonstrating Further Increases in SNALP Potency Feb 24, 2009 Tekmira Presents Data Demonstrating Further Increases in SNALP Potency 17.8 KB ... Read more Summary ToggleTekmira Publishes PLK1 SNALP Anti-Tumor Efficacy Data Feb 23, 2009 Tekmira Publishes PLK1 SNALP Anti-Tumor Efficacy Data 17.8 KB ... Read more Summary ToggleTekmira Partner Alnylam Presents Data on Programs Using Tekmira’s SNALP Technology at Keystone Meeting Feb 12, 2009 ... Read more Summary ToggleTekmira Partner Alnylam Receives Clearance from FDA to Initiate Clinical Trial Utilizing SNALP Jan 23, 2009 Tekmira Partner Alnylam Receives Clearance from FDA to Initiate Clinical Trial Utilizing SNALP 15.9 KB ... Read more Summary ToggleTekmira Announces $11.2 million 3-Year Manufacturing and Development Commitment from Partner Alnylam Jan 08, 2009 Tekmira Announces $11.2 million 3-Year Manufacturing and Development Commitment from Partner Alnylam 17.3 KB ... Read more Summary ToggleTekmira Partner Alnylam Files First IND for an RNAi Therapeutic Utilizing SNALP Dec 23, 2008 Tekmira Partner Alnylam Files First IND for an RNAi Therapeutic Utilizing SNALP 16.7 KB ... Read more Summary ToggleTekmira Pharmaceuticals Corporation Announces Third Quarter 2008 Operating Results and Provides Program Update Nov 13, 2008 Tekmira Pharmaceuticals Corporation Announces Third Quarter 2008 Operating Results and Provides Program Update 28.1 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory Nov 10, 2008 Tekmira Pharmaceuticals Conference Call Advisory 12.2 KB 2008 Third Quarter Operating Results ... Read more Pagination First page First Previous page Previous … Page 47 Current page 48 Page 49 Page 50 … Next page Next Last page Last
Tekmira Partner Alnylam Receives Clearance from FDA to Initiate Clinical Trial Utilizing SNALP 15.9 KB
Tekmira Announces $11.2 million 3-Year Manufacturing and Development Commitment from Partner Alnylam 17.3 KB
Tekmira Pharmaceuticals Corporation Announces Third Quarter 2008 Operating Results and Provides Program Update 28.1 KB